手术Apgar评分在头颈部鳞状细胞癌中的应用价值
本研究回顾性分析563例非皮肤头颈部鳞状细胞癌(HNSCC)手术患者,计算手术Apgar评分(SAS)。结果显示SAS越高,30天术后并发症发生率越低(SAS 0-4组61.5% vs SAS 9-10组9.7%,P < .0001),且低SAS与更长手术时间和住院时间相关。多因素分析中SAS仍为独立预测因素。
要点
- SAS与30天术后并发症呈负相关,SAS 0-4组并发症率61.5%。
- 低SAS组手术时间和住院时间显著更长(P < .0001)。
- SAS是多因素分析中30天并发症的独立预测因素。
核心结论
- 在非皮肤HNSCC患者中,SAS升高与30天术后并发症发生率显著降低相关。
研究设计与样本
- 回顾性病例系列研究,纳入2012年4月至2015年3月期间接受非皮肤HNSCC切除术的患者563例。
主要发现
- 30天术后并发症与SAS升高呈负相关(P < .0001)。
- 低SAS与手术时间延长(SAS 0-4:9.3 ± 2.6小时 vs SAS 9-10:3.0 ± 1.1小时)和住院时间延长(SAS 0-4:10.0 ± 7.3天 vs SAS 9-10:1.6 ± 1.0天)显著相关,P < .0001。
- 多因素分析调整潜在混杂因素后,SAS仍具有高度显著性(P < .0001)。
临床怎么用
- SAS可用于非皮肤HNSCC术后并发症风险的早期分层,低SAS患者需加强术后监护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objectives To recognize the utility of the surgical Apgar score (SAS) in a noncutaneous head and neck squamous cell carcinoma (HNSCC) population. Study Design Retrospective case series with chart review. Setting Academic tertiary medical center. Subjects and Methods Patients (n = 563) undergoing noncutaneous HNSCC resection between April 2012 and March 2015 were included. Demographics, medical history, intraoperative data, and postoperative hospital summaries were collected. SASs were calculated following the published schema. The primary outcome was 30-day postoperative morbidity. A 2-sample t test, analysis of variance, and χ2 (or Fisher exact) test were used for statistical comparisons. A multivariable logistic regression analysis was conducted to identify independent predictors of 30-day morbidity. Results Mean SAS was 6.2 ± 1.5. SAS groups did not differ in age, sex, or race. Sixty-five patients (11.6%) had a SAS between 0 and 4, with 40 incidences of morbidity (61.5%), while 31 (5.5%) patients with SAS from 9 to 10 had 3 morbidity occurrences (9.7%). Results show that 30-day postoperative morbidity is inversely related to increasing SAS ( P < .0001). Furthermore, lower SAS was associated with significantly increased operative time (SAS 0-4: 9.3 ± 2.6 hours vs SAS 9-10: 3.0 ± 1.1 hours) and lengths of stay (SAS 0-4: 10.0 ± 7.3 days vs SAS 9-10: 1.6 ± 1.0 days), P < .0001. SAS remained highly significant after adjusting for potential confounding variables in the multivariable analysis ( P < .0001). Conclusions An increasing SAS is associated with significantly lower rates of 30-day postoperative morbidities in a noncutaneous HNSCC patient population.
引用
- Prince AC, Day KE, Lin CP, et al. Utility of the Surgical Apgar Score in Head and Neck Squamous Cell Carcinoma. Otolaryngol Head Neck Surg. 2018. PMID: 29870298. doi:10.1177/0194599818767626
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。